Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on the day's biggest business stories
Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Sign up for Axios NW Arkansas
Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters
Results from the BinaxNOW COVID-19 Ag Card test will be available in roughly 15 minutes. Photo: Courtesy of Abbott Laboratories.
Abbott Laboratories said Wednesday it received emergency use authorization (EAU) from the Food and Drug Administration for its COVID-19 test that works without lab equipment.
The big picture: Abbott said it will ramp up production of its "highly portable," $5 tests to 50 million by the beginning of October.
- The tests, about the size of a credit card, use similar technology to at-home pregnancy tests, per Bloomberg.
- Results from the tests, called the BinaxNOW COVID-19 Ag Card, are available in roughly 15 minutes, the company said.
- Abbott added that the tests "demonstrated sensitivity of 97.1% (positive percent agreement) and specificity of 98.5% (negative percent agreement) in patients suspected of COVID-19 by their healthcare provider within the first seven days of symptom onset."
- Abbott will also launch a "first-of-its-kind" mobile app to "allow people who test negative to display a temporary digital health pass that is renewed each time a person is tested through their healthcare provider together with the date of the test result."
What they're saying: "The massive scale of this test and app will allow tens of millions of people to have access to rapid and reliable testing," Joseph Petrosino, professor at Baylor College of Medicine, said in a statement released by Abbott.
- "With lab-based tests, you get excellent sensitivity but might have to wait days or longer to get the results. With a rapid antigen test, you get a result right away, getting infectious people off the streets and into quarantine so they don't spread the virus," Petrosino added.
The state of play: The EUA comes as cities and states scramble to secure enough tests, and overcome long wait times for results.
- More than 73 million tests have been performed in the U.S., according to Johns Hopkins University.
Go deeper: Coronavirus dashboard